Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P17
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-5.29%
Q3 2025-4.87%
Q2 202534.98%
Q1 2025-6.66%
Q4 2024-4.79%
Q3 2024-3.83%
Q2 2024-4.00%
Q1 202462.87%
Q4 20239.21%
Q3 2023-5.83%
Q2 2023-4.55%
Q1 2023-5.64%
Q4 2022-2.67%
Q3 202246.52%
Q2 2022-5.63%
Q1 2022-4.38%
Q4 2021-3.13%
Q3 2021-2.98%
Q2 2021-2.49%
Q1 2021137.35%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%